1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2640 | Rebastinib | DCC2036 , DCC 2036 , DCC-2036 | FLT , Apoptosis , Src , Bcr-Abl |
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Re... |